$0 is the total value of Index Venture Associates III Ltd's 1 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | Nonen/a | $0 | – | 0 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OZON HLDGS PLC | 5 | Q4 2021 | 100.0% |
| None | 3 | Q3 2022 | 0.0% |
View Index Venture Associates III Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Minerva Neurosciences, Inc. | June 18, 2019 | 2,297,995 | 5.9% |
| Egalet Corp | February 14, 2018 | 1,386,602 | 3.2% |
| Aegerion Pharmaceuticals, Inc. | January 23, 2013 | 1,031,827 | 4.1% |
View Index Venture Associates III Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-13 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-12 |
| 4 | 2019-06-26 |
| 4 | 2019-06-21 |
View Index Venture Associates III Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.